期刊文献+

依达拉奉对伴胰岛素抵抗急性脑梗死患者细胞因子的影响 被引量:3

Effect of edaravone on inflammatory cytokines in serum of acute cerebral infarction patients with insulin resistance
原文传递
导出
摘要 目的观察依达拉奉对急性脑梗死合并胰岛素抵抗患者肿瘤坏死因子α(TNF-α)、白细胞介素6(IL-6)水平的影响。方法选择住院治疗急性脑梗死合并胰岛素抵抗患者90例,随机分为两组,每组45例,对照组采用常规治疗,观察组在对照组治疗的基础上加用依达拉奉治疗,同时选10例健康人做健康对照,连续监测血清中TNF-α、IL-6的动态变化;并于治疗后第7、14d进行临床疗效评定。结果两组患者治疗前TNF-α、IL-6水平均高于健康对照组(P<0.05)。观察组患者治疗后第5d TNF-α、IL-6水平恢复至健康对照组水平,对照组患者在治疗后第7d时,TNF-α及IL-6水平均高于观察组患者及健康对照者(P<0.05)。与对照组比较,观察组治疗后第7d、第14d BI评分明显升高、治疗后第14d SSS评分明显降低(P均<0.05);观察组治疗后第14d FINS、HOMA-IR明显改善(P<0.05)。结论急性脑梗死患者合并胰岛素抵抗患者予依达拉奉治疗可降低血清中TNF-α、IL-6水平,降低胰岛素抵抗,改善患者预后。 Objective To investigate the effect of edaravone on inflammatory eytokines in serum of acute cerebral infarction patient with insulin resistances. Methods Ninety acute cerebral infarction patients were randomly divided into observation group and control group. The patients in control group were given routine treatment and the patients in observation group were given edaravone besides routine therapy. Ten serum samples from healthy persons were taken as healthy control. The levels of TNF-α, IL-6 were determined continuously and the clinical efficacy in both groups were evaluated on the 7th and 14th day after treatment. Results The levels of TNF-α and IL-6 in the patients of both groups before the treatment were significantly higher that of the healthy controls (P〈0.05). The levels of TNF-α and IL-6 in patients of observation group drooped to the level of the healthy controls on the 5d after treatment. The levels of TNF-α and IL-6 in patients of the control group were higher than those in the observation group and the healthy control(P〈0.05 ).Compared with the control group, the BI scores in the observation group were increased greatly on the 7th day and 14th day after treatment. And the SSS scores decreased on 14th day (P〈0.05).Conclusions Edaravone can erduce the levels of TNF-a and IL-6 as well as low insulin resistance and improve the prognosis, Thus it is effective for treatment of patients with acute cerebral infarction.
出处 《中国热带医学》 CAS 2014年第9期1105-1107,共3页 China Tropical Medicine
关键词 急性 脑梗死 依达拉奉 细胞因子 胰岛素抵抗 Acute Cerebral infarctin Edaravone Cytokine Insulin resistance
  • 相关文献

参考文献11

  • 1Yan J, Greer JM.McCombe PA. Prolonged elevation of cytokine levels after human acute ischaemic stroke with evidence of individual vari- ability [J]. J Neuroimmunol,2012,246 : 78.
  • 2Xu Q, Paik MC, Rundek T,et al. Reweighting estimators for Cox regres- sion with missing covariate data: analysis of insulin resistance and risk of stroke in the Northern Manhattan Study [J]. Stat Med, 2011,30(28): 3328-3340.
  • 3李世英,闫冰,臧贺川,郭静.脑梗死患者的亚临床炎症及胰岛素抵抗[J].临床神经病学杂志,2008,21(6):416-418. 被引量:2
  • 4Patel RD, Saver JL. Evolution of reperfusion therapies for acute brain and acute myocardial ischemia: a systematic, comparative analysis [J].Stroke, 2013,44(1 ) : 94-98.
  • 5Tuttolomondo A, Di Raimondo D, Pecoraro R ,et al. Inflammation in ischemic stroke subtypes [J]. Curt Pharm Des, 2012,18(28): 4289-4310.
  • 6Clark N, Cast illo J, Davalos A, et al . Proinilammatory cytokines and early neurological worsening in ischemic stroke [J]. Stroke, 2000, 31: 2325 -2329.
  • 7Liesz A, RUger H, Purrucker J, Zorn M ,et al. Stress mediators and im- mune dysfunction in patients with acute cerebrovascular diseases [J]. PLoS One, 2013,19,8(9):e74839.
  • 8王朝辉,李保平.依达拉奉对脑梗死患者血清中TNF-α和IL-8影响[J].第四军医大学学报,2006,27(19):1789-1791. 被引量:11
  • 9郑佳,陈旭.依达拉奉对急性脑梗死合并胰岛素抵抗患者的疗效观察[J].中华老年心脑血管病杂志,2013,15(10):1015-1017. 被引量:13
  • 10陈杰,惠威,徐斌等.肝硬化合并肝源性糖尿病患者血清细胞因子水平分析[J].中华临床医师杂志:电子版,2013,7(8):3270-3272.

二级参考文献20

  • 1顾学兰,丁新生,狄晴,赵忠新,陈家慧,李健华.依达拉奉注射液治疗急性脑梗死的临床疗效评价[J].中国新药与临床杂志,2005,24(2):113-116. 被引量:172
  • 2林兴建,张颖冬.脑血管病患者血浆抵抗素水平与胰岛素抵抗的相关性研究[J].临床神经病学杂志,2005,18(2):88-90. 被引量:11
  • 3各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33055
  • 4Garcia JH,Liu KF,Yoshida Y,et al.Influx of leukocytes and plateles in an evolving brain infarct(wistar rat)[J].Am J Pathol,1994,144(1):188-199.
  • 5Yang GY,Schieike GP,Gong C,et al.Expression of yumor necrosis factor-alpha and intercellular adhesion molecule-1 after cerebral ischemia in interleukin-1 beta converting enzyme deficient mice[J].J Cereb Flow Metab,1999,19(10):109-117.
  • 6Lavine SD,Hofman FM,Zlokovic BV.Circulating antibody against tumor necrosis factor-alpha protects rat brain from reperfusion injury[J].J Cerebr Blood Flow Metab,1998,16(1):52.
  • 7Yamasaki Y,Matsuo Y,Matsuura N,et al.Transient increase of cytokin-induced neutrophil chemoattractant,a menmber of the interleukin-8 family,in ischemic brain areas after ischemia in rats[J].Stroke,1995,26(1):318-323.
  • 8Gast KB, Tjeerdema N, Stijnen T, et al. Insulin resistance and risk of incident cardiovascular events in adults without diabe- tes : meta-analysis. PLoS One, 2012,7 : e52036.
  • 9Rundek T, Gardener H, Xu Q, et al. Insulin resistance and risk of isehemic stroke among nondiabetic individuals from the northern Manhattan study. Arch Neurol, 2010, 67.. 1195 1200.
  • 10Yamashita T, l)eguehi K, Nagotani S, et al. Vascular protec tion and restorative therapy in ischernic stroke. Cell Trans plant,2011,20 95 97.

共引文献23

同被引文献31

引证文献3

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部